QA: CASSAVA SCIENCES INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069530_2023_CASSAVA_SCIENCES_INC.pdf

Logs

Graph

Absolute values for 0001069530, CASSAVA SCIENCES INC

  xvar xval
0 AssetsCurrent 211,226,000
1 IntangibleAssetsNetIncludingGoodwill 622,000
2 PropertyPlantAndEquipmentNet 22,864,000
3 remainder_Assets 122,000
4 LiabilitiesCurrent 7,063,000
5 LiabilitiesNoncurrent 232,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,988,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 68,032,000
11 remainder_Revenues 2,777,000
12 remainder_NetIncome 997,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 234,834,000
1 Liabilities 7,295,000
2 Expenses 80,020,000
3 Revenues 2,777,000
4 StockholdersEquity 227,539,000
5 NetIncome -76,246,000
6 ComprehensiveNetIncome -76,246,000
7 BaseVar 162,961,500
8 EconomicCapitalRatio 2.60

Edgar->Model Mapping

Feature Distribution

Change over Time